IL6 and liver cancer: Higher BMP2 expression was found in the liver of patients with human hepatocellular carcinoma than that of normal liver tissues, and exogenous BMP2 injected into mice enhanced liver cancer growth through the activation of myeloid-derived suppressor cells to secret more IL6, which could promote cell proliferation of liver cancer cells [70].